GENASSIST THERAPEUTICS
GenAssist Therapeutics develops gene therapy drugs using base editing technology, which is advantageous in the field of DMD treatment. Founded in 2020, GenAssist was founded by outstanding scientists and industry experts in July 2020. They are committed to the development of gene editing drugs for a variety of genetic diseases.
GENASSIST THERAPEUTICS
Industry:
Health Care Medical Therapeutics
Founded:
2020-01-01
Address:
Suzhou, Jiangsu, China
Country:
China
Website Url:
http://www.genassisttx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Current Employees Featured
Founder
Investors List
Redhill Capital
Redhill Capital investment in Seed Round - GenAssist Therapeutics
Official Site Inspections
http://www.genassisttx.com
- Host name: 47.88.91.184
- IP address: 47.88.91.184
- Location: San Mateo United States
- Latitude: 37.5517
- Longitude: -122.33
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94402
More informations about "GenAssist Therapeutics"
Genassisttx
Founded in July 2020, GenAssist Ltd. (GenAssist) is a pioneering gene editing drug company. The operation entity of GenAssist is located in Suzhou, China, with two subsidiaries in …See details»
GenAssist Therapeutics - Crunchbase Company Profile …
Contact Email [email protected] GenAssist Therapeutics develops gene therapy drugs using base editing technology, which is advantageous in the …See details»
GenAssist Therapeutics Co., Ltd | 领英 - 领英 (中国)
GenAssist Therapeutics Co., Ltd | 在领英上有 21 位关注者。Innovation Creates Hope | GenAssist Therapeutics is a leading base editing company founded in July 2020. Th headquarter is …See details»
Suzhou Genassist Therapeutics Co Ltd. - Drug pipelines, Patents ...
Www.genassisttx.com. Startups | Private Company | 2020 | Jiangsu Sheng, China | < 10 | www.genassisttx.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational …See details»
GenAssist Therapeutics - PitchBook
GenAssist Therapeutics General Information Description. Developer of gene editing drugs for a variety of genetic diseases. The company owns global intellectual property rights of TAM …See details»
Company: GenAssist Therapeutics - crisprmedicinenews.com
GenAssist Therapeutics is a biotech company based in China focusing on the development of advanced and optimised base-editing therapeutics to treat Duchenne muscular dystrophy …See details»
GenAssist Therapeutics - Products, Competitors, Financials, …
Genassisttx.com. Overview & Products; Financials; Founded Year 2020. Stage Series A | Alive. Mosaic Score. The Mosaic Score is an algorithm that measures the overall financial health and …See details»
GenAssist, a Pioneer in the field of the Gene Editing Innovative …
Dec 14, 2023 On July 9, 2021, GenAssist has successfully closed a multi-million RMB Pre-Series A financing , bringing the total raised funds to nearly 100 million RMB.The round was …See details»
Suzhou Genassist Therapeutics Co Ltd. - synapse.zhihuiya.com
了解Suzhou Genassist Therapeutics Co Ltd. (苏州新芽基因生物技术有限公司)公司的药物管线，治疗领域，技术平台，以及它的47篇新闻，疾病领域:神经系统疾病，技术平台:基因疗法， …See details»
GenAssist Completes Multi-Million Dollar Series A Financing
Dec 14, 2023 Recently, GenAssist, which is the first company in China to develop gene therapy drugs using base editing technology, announced the closing of a multi-million dollar Series A …See details»
Suzhou GenAssist Therapeutics - VentureRadar
Similar Companies: Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, …See details»
GENASSIST - Crunchbase Company Profile & Funding
GENASSIST is a genetics company that provides assisted reproductive technology genetic consultation and testing services.See details»
GenAssist - Products, Competitors, Financials, Employees, …
For more information, please visit www.genassisttx.com , Contact: [email protected] . Source: GenAssist Therapeutic Co.,Ltd. Sep 9, 2024. GenAssist Ltd Announced the First DMD …See details»
新芽基因-动脉网 - vbdata.cn
Jul 2, 2020 新芽基因是一家全球领先的基因编辑药物研发公司。公司拥有自主知识产权碱基编辑器tam全球权利，也是全球极少数利用碱基编辑技术进行全身性给药的基因治疗公司之一。公 …See details»
Science – Genassisttx
Former Director of the Quality Assurance Department and Laboratory at the Shanghai Institute of Biological Products. Research and establishment of quality standards for various viral …See details»
新芽基因（GenAssist）完成数千万美元A轮融资_创投之家
Dec 8, 2022 国内首家利用碱基编辑技术进行基因治疗药物研发的公司，新芽基因（GenAssist）宣布完成了数千万美元A轮融资。本轮融资由阿斯利康中金医疗产业基金领 …See details»
GenAssist Raises “Millions of Dollars” for Novel Base Editing Drugs
Dec 8, 2022 Suzhou GenAssist Therapeutics raised “millions of dollars” in an A round to support its gene editing drugs that target neuromuscular diseases. Founded in 2020, the company …See details»
GenAssist Ltd Announced the First DMD Patient Dosed with its …
SUZHOU, China, Sept. 9, 2024 /PRNewswire/ -- On September 06, 2024, GenAssist Ltd (GenAssist), announced the first DMD patient dosed with its base editing drug, GEN6050X …See details»
GenAssist expressed great gratitude to the valuable advice from …
Dec 29, 2023 Suite 423, A2, No.218 Xinghu Street, Suzhou, China| Phone: (+86) 0512-67249963 | Email: [email protected]See details»
GenAssist
Today Over 250,000 traumatic muscle injuries every year. 60% of muscle trauma injuries are left untreated >80% of delayed amputations are caused by muscle trauma. 90% of medical …See details»